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HIV-associated tuberculosis (TB) continues to pose a 
considerable global public health threat. In 2010, 1.1 million 
(13%) of the 8.8 million new TB cases globally were among 
people living with HIV (PLWH) and HIV accounted for 25% 
of the 1.4 million TB deaths. South Africa ranked third in the 
number of incident TB cases in 2010 with an estimated 61% of 
TB patients infected with HIV. Despite important efforts to curb 
the TB epidemic, South Africa (SA) was the only high-burden 
country where the TB burden continued to rise in 2010.1
To address the HIV-associated TB epidemic, in 2004 the World 
Health Organization (WHO) published the Interim Policy on 
Collaborative TB/HIV activities.2 To decrease the burden 
Background. In 2004 the World Health Organization 
(WHO) released the Interim Policy on Collaborative TB/
HIV activities. According to the policy, for people living with 
HIV (PLWH), activities include intensified case finding, 
isoniazid preventive therapy (IPT) and infection control. For 
TB patients, activities included HIV counselling and testing 
(HCT), prevention messages, and cotrimoxazole preventive 
therapy (CPT), care and support, and antiretroviral therapy 
(ART) for those with HIV-associated TB. While important 
progress has been made in implementation, targets of the 
WHO Global Plan to Stop TB have not been reached. 
Objective. To quantify TB/HIV integration at 3 primary 
healthcare clinics in Johannesburg, South Africa.
Methods. Routinely collected TB and HIV data from the 
HCT register, TB ‘suspect’ register, TB treatment register, 
clinic files and HIV electronic database, collected over a 
3-month period, were reviewed. 
Results. Of 1 104 people receiving HCT: 306 (28%) were 
HIV-positive; a CD4 count was documented for 57%; and 
few received TB screening or IPT. In clinic encounters 
among PLWH, 921 (15%) had documented TB symptoms; 
only 10% were assessed by smear microscopy, and few 
asymptomatic PLWH were offered IPT. Infection control 
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was poorly documented and implemented. HIV status was 
documented for 155 (75%) of the 208 TB patients; 90% 
were HIV-positive and 88% had a documented CD4 count. 
Provision of CPT and ART was poorly documented.
Conclusion. The coverage of most TB/HIV collaborative 
activities was below Global Plan targets. The lack of 
standardised recording tools and incomplete documentation 
impeded assessment at facility level and limited the accuracy 
of compiled data. 
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of TB in PLWH, the guidelines recommend 
intensified TB case-finding (ICF), isoniazid 
preventive therapy (IPT) and infection control 
in healthcare and congregate settings. In 2008, 
these activities were packaged as the ‘3Is’. To 
decrease the burden of HIV in TB patients, 
the guidelines promote HIV counselling and 
testing (HCT) and HIV prevention methods 
for all TB patients, and cotrimoxazole 
preventive therapy (CPT) and HIV/AIDS care 
and support including antiretroviral therapy 
(ART) for those co-infected. 
In 2006, the Stop TB Partnership launched 
the ‘Global Plan to Stop TB 2011 - 2015’, 
providing a roadmap for scaling up prevention 
and treatment and research and development.3 
The plan outlined specific TB/HIV 
collaboration targets, providing a framework 
for measuring WHO TB/HIV collaborative 
activities.
Despite an increasing body of evidence on 
the effectiveness and feasibility of collaborative 
TB/HIV activities and recent improvements in 
TB/HIV integration, implementation remains 
below targets.1,3 In 2010, key global indicators 
included merely 12% of eligible patients 
initiating IPT, and only 34% of TB patients 
were reported to know their HIV status.1
We reviewed routine TB and HIV data to 
quantify TB/HIV integration, measured against 
WHO and Global Plan targets,1,3 at 3 primary 
healthcare clinics in Johannesburg, SA.
Methods
Study setting and 
population 
Three primary healthcare clinics in the 
Johannesburg metropolitan area were 
purposefully selected to represent different 
geographical catchment areas and non-
governmental and Department of Health 
(DoH) clinics. All clinics provided TB 
diagnosis and treatment services, HCT, pre-
ART care, and continuation of ART for stable 
patients. Two sites also served to initiate ART. 
TB and HIV services were performed vertically 
in different areas of the clinic by different staff 
who self-identified as either ‘TB’ or ‘HIV’ staff.
HIV counselling and testing was 
performed in those who requested this 
service, and provider-initiated HCT was 
offered to pregnant women and clients with 
AIDS symptoms, including TB and sexually 
transmitted diseases. CPT was indicated in 
PLWH with a CD4 count <200 cells/mm3, 
as well as in symptomatic HIV disease and 
in all TB patients.4 PLWH were eligible for 
ART if their CD4 count was <200 cells/mm3 
and/or they met the WHO criteria of stage 4 
disease.5 PLWH were eligible for IPT if they 
were asymptomatic for TB and had a positive 
tuberculin skin test (TST), or they were a TB 
contact.4 Clinic clients with cough persisting 
for longer than 2 weeks were considered TB 
suspects, independent of HIV status. The first-
line diagnostic for TB was smear microscopy. 
Smear-negative TB suspects were assessed 
further by culture (sputum analysis performed 
by the centralised National Health Laboratory 
Service) and chest X-ray (performed at nearest 
hospital).4 
All clients who presented to 1 of the 3 
selected clinics between 19 August and 19 
October 2009 and who received TB and/or 
HIV services were included for analysis. 
Eligible clients were identified by review of 
relevant data sources, including the paper 
SA National DoH HCT register, TB case 
identification and follow-up register, TB 
treatment register, and an electronic HIV 
database (TherapyEdge) (Table 1). Records of 
all eligible individuals were reviewed 2 months 
after their clinic visit to allow sufficient time 
for activities to be performed and results to be 
captured. Infection control was assessed using 
a standardised risk assessment tool based on 
National TB Infection Control guidelines.6
Individuals were categorised as: ‘HCT 
clients’ if they received HCT during the study 
period; ‘TB suspect’ if they had a diagnostic 
sputum investigation recorded; and ‘TB 
patient’ if they were started on TB treatment 
during the study period. As the WHO 
guidelines recommend symptom screening 
at every clinic visit, we included all PLWH 
encounters, including multiple encounters by 
individual PLWH that occurred during the 
specified time period.
Clinic records of clients who were newly 
tested HIV-positive were reviewed for 
documentation of TB symptom screening. 
Names were cross-checked with the ‘TB 
Detection and Follow up Sputum Register’ 
to assess if a sputum specimen was obtained. 
Data on PLWH were extracted from the 
TherapyEdge database. For every encounter 
registered, recorded symptoms and signs were 
reviewed. For every PLWH with recorded 
cough, night sweats, weight loss, axillary 
nodules or fever, the ‘TB Detection and 
Follow up Sputum Register’ was cross-checked 
to assess if a sputum specimen had been 
obtained. Files of clients entered into the TB 
Case Identification and Follow up Register 
Table 1. Definition of study participants, data sources and activities reviewed
Definition Source
TB and HIV activities
performed Reviewed (N)





Staging by CD4 count
1 104
PLWH encounters Clinic visits by PLWH Electronic HIV database
TB case identification 
register
Intensified TB screening
Referral for TB investigation (if 
symptomatic)
6 157
TB suspects Clinic client with record 
of diagnostic sputum 
investigation




Diagnostic assessment of TB suspect
HCT
CPT and ART (if eligible)
602
TB patients starting 
TB treatment
Clinic client with TB start 





Staging by CD4 count 
ART if eligible
208
HCT = HIV counselling and testing; PLWH = people living with HIV; CPT = cotrimoxazole preventive therapy; ART = antiretroviral therapy; TB = tuberculosis.











and/or the TB register were reviewed for 
HIV testing, CD4 count, CPT status and ART 
status. 
All data from standardised National DoH 
registers and TherapyEdge were entered for 
analysis in an electronic TB/HIV clinic and 
patient management program (eMuM®). 
Descriptive statistics were used to characterise 
the study population. Statistical analyses were 
performed with SAS software (version 9.2). 
The Global Plan targets3 were used as the 
standards against which the implementation 
of these activities was measured. The study 
was approved by the Human Research 
Ethics Committee of the University of the 
Witwatersrand, the Institutional Review 
Board of the University of North Carolina, the 
City of Johannesburg Health Department, and 
facility managers. 
Results
Activities to reduce the 
burden of TB among PLWH
HCT clients were young (median age of 27 
years) and the majority were female (75%). 
Of the 1 104 clients tested, 306 (28%) were 
HIV-positive. Only 57% of HIV-positive 
patients had a CD4 count result recorded, 
with a median count of 336 cells/mm3 (IQR 
152 - 502). The proportion of clients newly 
diagnosed with HIV who were screened for 
TB symptoms could not be determined, as this 
activity was not systematically recorded. Based 
on review of the TB case identification register, 
only 2/306 (0.6%) HIV-positive HCT clients 
were assessed by smear microscopy at the time 
of their HCT visit. 
There were 6 157 clinic encounters for 4 079 
individual PLWH. The majority (79%) were for 
patients receiving ART (Table 2). The proportion 
of individuals with any recorded TB symptom of 
any duration was slightly higher for pre-ART 
than ART visits (17% v. 14%; p=0.04). In both 
populations, coughing was the most frequently 
recorded symptom (85% and 70%, respectively). 
Of the 921 clinic encounters with documented 
TB symptoms, only 91 (10%) resulted in 
sputum collection, with similar proportions of 
pre-ART and ART suspects being investigated 
(12% and 9%, respectively, p=0.20). Among the 
91 TB suspects investigated, 8 smear-positive 
pulmonary TB cases and 9 smear-negative 
culture-positive TB cases were diagnosed. A 
culture result was missing or contaminated in 
27% (22/83) of smear-negative TB suspects.
The clinics did not collect information on 
IPT in an IPT register, pre-ART register or 
in the electronic HIV system, making an 
accurate estimate of the number of people 
receiving IPT difficult. According to the clinic 
directors, a small number of PLWH received 
IPT in 1 clinic; the other 2 clinics did not 
provide IPT.
An infection control plan existed in 2 sites, 
and posters on cough hygiene were displayed 
in all 3 facilities. Staff training was ad hoc; 
management reported that an effort was 
made to educate staff on TB and encourage 
them to know their HIV status and seek 
appropriate care. There was no triage system 
or fast-tracking of patients with coughing. 
Environmental controls were inconsistently 
used, 30% of windows remained closed. One 
site had ultraviolet germicidal irradiation in 
Table 2. Intensified TB case finding during 6 157 clinic encounters 








Total, N (%) 6 157 (100) 1 274 (21) 4 883 (79)
Any TB symptom recorded,* n (%) 921 (15) 214 (17) 707 (14) 0.04
Cough 678 (74) 181 (85) 497 (70)
Weight loss 138 (15) 38 (18) 100 (14)
Night sweats 169 (18) 27 (13) 142 (20)
Lymphadenopathy 79 (9) 14 (7) 65 (9)
Fever 58 (6) 14 (7) 44 (6)
Investigated for TB (if symptomatic), n (%) 91 (10) 26 (12) 65 (9) 0.20
Smear-positive 8 (9) 2 (8) 6 (9)
Smear-negative, culture-negative 52 (57) 17 (65) 35 (54)
Smear-negative, culture-positive 9 (10) 1 (4) 8 (12)
Smear-negative, culture missing/
contaminated 22 (27) 6 (23) 16 (25)
*Patients may have reported more than one symptom.
Fig 1. HIV counselling and testing among 208 TB patients registered at 3 primary care clinics in 
Johannesburg, South Africa.







the TB clinic area. Personal protection for 
staff interacting with patients in the form of 
N95 respirator or surgical masks was available 
at one clinic, but use was not enforced. 
TB disease in healthcare workers was not 
documented. 
Activities to reduce the 
burden of HIV among TB 
patients
Among the 602 TB suspects, 173 (29%) were 
known HIV-positive before their suspect 
visit but only half were documented as 
receiving HIV care (Table 3). Among the 429 
TB suspects with unknown HIV status, 217 
(51%) had a record of HCT offer. Of these, 110 
(51%) were HIV-positive, 43 (20%) were HIV-
negative, and 64 (29%) refused HIV testing. 
Overall, HIV status was recorded in 54% of TB 
suspects; 73% (95% CI 0.83 - 0.90) were HIV-
infected. 
A CD4 cell count was documented in 78% 
(222/283) of HIV-positive TB suspects. The 
proportion of suspects staged by CD4 count 
and the median CD4 count did not differ 
significantly between those with known status 
at time of presentation and those tested on 
the day of the TB suspect visit (76% v. 82%, 
respectively; p=0.27; and 190 (IQR 90 - 351) 
v. 183 (IQR 61 - 289) cells/mm3, respectively). 
Among the 602 TB suspects, 143 (24%) 
were diagnosed with active TB: 80 (56%) 
with smear-positive TB, 25 (17%) with smear-
negative culture-positive TB, 27 (19%) based 
on clinical and/or radiological criteria and 
11 (8%) with extrapulmonary TB. Among 
the 494 smear-negative TB suspects, a culture 
was requested in 345 (70%). The culture was 
positive for Mycobacterium tuberculosis in 5%, 
negative in 48%, and had missing results in 
17%. TB  treatment was initiated in only 81% 
(65/80) of TB suspects who were positive on 
smear microscopy and 26% (7/27) of smear-
negative suspects with a positive culture. 
During the 3-month study period, 208 
patients received TB treatment – the majority 
(81%) for pulmonary TB. The proportion 
of TB patients aware of their HIV status 
increased from 39% before TB diagnosis to 
66% at time of TB treatment initiation, and 
to 75% during TB treatment (Fig. 1). Among 
the 155 TB patients with known HIV status, 
90% were HIV-positive. A CD4 count was 
documented for almost all HIV-positive TB 
patients (88%). The median CD4 count was 
131 cells/mm3 (interquartile range (IQR) 60 
- 235), and the vast majority (107/123; 87%) 
had a CD4 count <350 cells/mm3. There was 
no documentation of HIV prevention and 
counselling for HIV-positive or -negative 
patients, but condoms were freely available 
at all 3 clinics. According to the staff, most 
HIV-positive TB patients received CPT, but 
the proportion receiving such therapy could 
not be quantified as it was not documented in 
the TB register, nor consistently recorded in 
patient files. ART status was not consistently 
recorded, and patients receiving TB treatment 
at a clinic not accredited for ART initiation 
might have initiated ART in another facility, 
making accurate reporting of the proportion 
receiving ART impossible. 
Discussion
In this quantitative evaluation of collaborative 
TB/HIV activities at 3 primary healthcare 
clinics, we confirmed the magnitude of the 
TB/HIV epidemic and observed strengths 
and gaps in the fight against TB/HIV at 
primary care level. However, our analysis was 
challenged by weaknesses in the routine data 
required to report on WHO core indicators 
developed to monitor TB/HIV activities. 
The most important strength observed 
was the high rate of HIV and CD4 testing 
achieved among TB patients (75% and 88%, 
respectively). Important gaps included the lack 
of full TB/HIV integration despite availability 
of all services at one facility. Firstly, ART 
coverage among patients with TB could not 
be ascertained as ART was not documented in 
the TB register or on the TB treatment card. 
Secondly, integration of TB services into pre-
ART care was poor. Patients newly diagnosed 
with HIV were not routinely screened for TB, 
even though a simple TB symptom screen 
could successfully have been integrated.7 
People newly diagnosed with HIV were not 
offered IPT, even though most might have 
been eligible considering that the median CD4 
count was 336 cells/mm3 (higher than the 
median CD4 count of 111 cells/mm3 recorded 
in large ART cohorts in sub-Saharan Africa).8 
Thirdly, TB screening for people enrolled 
in HIV care was suboptimal. A formalised 
TB symptom screen was not performed and 
the TB screening outcome was not recorded 
as ‘no signs’, ‘suspect’, ‘on treatment’ or ‘not 
assessed’, as per WHO recommendations.9 
Consequently, healthcare workers rarely acted 
upon the information. Only 10% of those 
presenting with symptoms of TB were assessed 
by microscopy, and IPT was initiated in only a 
few asymptomatic PLWH. The ‘Proportion 
of symptomatic PLWH assessed for TB’ may 
be a useful additional indicator. Finally, while 
Table 3. HIV activities recorded among 602 TB suspects at 3 primary 
care clinics in Johannesburg, South Africa
HIV counselling and testing, n (%) 
Known HIV-positive before TB suspect visit 173 (29)
Referred from pre-ART care 26 (15)
Referred from ART clinic 65 (38)
No documentation of HIV care 80 (46)
HCT at time of TB suspect visit (if unknown HIV status), n (%)
Record of HIV counselling and/or testing 217 (51) 
HIV-positive 110 (51)
HIV-negative 43 (20)
HIV testing offered but refused 64 (29)
No record of HIV counselling or testing 212 (49)
TB suspects with documented HIV status at end of TB suspect visit 326 (54)
HIV prevalence rate among TB suspects with recorded HIV 
status, % (95% CI) 73 (0.83 - 0.90)
Staging by CD4 count 
Recorded CD4 count, n (%)
Known HIV-positive before TB suspect visit 132 (76)
Newly diagnosed HIV infection at time of TB suspect visit 90 (82)
Median CD4 count, cells/mm3 (IQR)
Known HIV-positive before TB suspect visit 190 (90 - 351)
Newly diagnosed HIV infection at time of TB suspect visit 183 (61 - 289)











some steps were taken towards TB infection 
control, this was not formally documented. 
The use of a standardised TB infection 
control risk assessment tool on a quarterly 
basis could facilitate monitoring. Given the 
lack of monitoring at facility level, it is not 
surprising that global data are lacking on the 
proportion of healthcare facilities providing 
services for PLWH that have TB infection 
control practices (indicator B.3.1) and the 
proportion of healthcare workers who develop 
TB (indicator B.3.2).9 
We also observed shortcomings in non-
integrated services. With regard to TB services, 
only 67% of patients with a microbiological 
diagnosis of TB initiated treatment, indicating 
important initial default of patients. Culture 
results were missing for 17% of specimens 
sent, resulting in poor service quality and a 
waste of resources. This could be improved 
by the introduction of more sensitive TB 
diagnostic tools with potential for use at 
point-of-care – such as the Xpert MTB/RIF10 
test and the lipo-arabinomanna (LAM)11 
assay. With regard to HIV services, a CD4 
count was recorded for only 56% of people 
newly diagnosed with HIV, again suggesting 
a failure to engage and retain patients in care. 
The scarcity of data hampered a comparison 
of our findings with those observed in other 
settings. Many have discussed the challenges 
of TB/HIV integration;7,12-14 however, 
most data are aggregated at country level 
and accurate reporting is complicated by 
the existence of 2 vertical programmes.15 
Coverage of the different components at 
facility level is not well described. Only 2 
other quantitative assessments at facility level 
have been published: in 2000 - 2002, Coetzee 
et al.16 observed many missed opportunities 
for TB and HIV prevention, diagnosis and 
management at primary care clinics in 
Khayelitsha; and in 2006, Scott et al.17 audited 
TB/HIV integration at 16 clinics in Cape 
Town, using a rapid (2 hours per clinic) audit 
tool and found poor capacity and weaknesses 
in quality and continuity of care.17 
Despite our comprehensive review of 
data on a large number of clinic clients, our 
study suffered limitations. To assess routine 
care, data collection was retrospective; 
consequently, activities that were performed 
but not recorded could not be assessed. 
Furthermore, clients may have received care 
at other clinics, but we were unable to verify 
this due to the high number of clinics in 
the City of Johannesburg (n=90). Data were 
only reviewed on adult clinic clients; an 
assessment of TB/HIV activities in children 
would have been complementary. Finally, 
SA underwent significant policy changes 
regarding collaborative TB/HIV since the 
review was undertaken. ART eligibility criteria 
changed to a CD4 count <350 cells/mm3 for 
TB patients and pregnant women, and ART is 
currently indicated for all multi-drug resistant 
Table 4. Coverage of TB/HIV activities compared with 2010 estimates for SA1 and The Global Plan to Stop TB 
targets3
Indicator9
Global Plan target 
(2011 - 2015) SA
Three primary care clinics in 
Johannesburg
Percentage of HIV-positive patients screened for TB 
in HIV care and treatment settings (indicator B.1.1) 
100% 758 837 •	 Not recorded at HCT 
•	 100% of PLWH in care screened 
for TB symptoms
•	 10% of TB suspects assessed by 
smear microscopy
Percentage of new HIV-positive patients starting 
IPT (indicator B.2.1)
100% 124 059 (12%) •	 0% at 2 clinics
•	 Small proportion at 1 clinic
Proportion of healthcare facilities providing services 
for PLWH that have infection-control practices 
including TB control (indicator B.3.1)
Target not set but 100% 
implied
NR None satisfied the requirements of 
indicator B.3.1
Proportion of healthcare workers employed in 
facilities providing care for PLWH who developed 
TB (indicator B.3.2)
Equal to background 
rate
NR NR
Proportion of TB patients with known HIV status 
(indicator C.1.1)
100% 54% 75%
Proportion of all registered TB patients with 
documented HIV status who are HIV-positive 
(indicator C.1.2.1)
NA 60% 90%
Availability of free condoms at TB services 
(indicator C.2.1)
100% NR 100%
Proportion of HIV-positive TB patients who receive 
CPT (indicator C.3.1)
100% 74% High according to healthcare 
worked, but poorly documented
Proportion of HIV-positive TB patients enrolled in 
HIV care services during TB treatment (indicator 
C.4.1)
100% NR Poorly documented
Proportion of HIV-positive registered TB patients 
given ART during TB treatment (indicator C.5.1)
100% 54% Poorly documented
NA = not available; NR = not recorded.







TB patients, regardless of CD4 count. The 
revised IPT guidelines removed the need for 
TST and included patients with previous TB 
and those on ART. 
Conclusion
Despite the existence of effective 
interventions, clear policies and guidelines, 
the TB/HIV epidemic continues to rage. It 
is encouraging that most TB/HIV activities 
were implemented at the primary care clinics, 
but unfortunately, at coverage levels well 
below the Global Plan targets (Table 4).1 This 
highlights the vast number of opportunities to 
improve TB control and HIV care as we move 
towards meaningful TB/HIV integration. The 
poor quality of routine data was of concern, 
especially given that primary care clinics are 
expected to compile data from these sources 
to report to district and national levels for 
aggregation, analysis, dissemination and 
management of the TB and HIV programmes. 
Collection of TB/HIV collaborative data 
can be complicated by privacy concerns,18 
the need to share data between 2 vertical 
programmes, and the lack of investment in 
monitoring and evaluation tools.15 Accurate 
monitoring of TB/HIV activities at all levels 
(facility, district, national and global) requires 
rationalisation and standardisation,18-19 
with appropriate treatment cards, registers, 
cohort reporting forms, and supportive 
supervision.9,19 The implementation of 
integrated TB/HIV electronic data collection 
and clinic management tools has the potential 
to galvanise TB/HIV integration at primary 
care level. We need to ensure that every action 
is properly recorded and that every loop is 
closed from diagnosis to treatment of TB and 
HIV, to result in fully integrated patient care.
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